During the pandemic, oncology researchers had to rapidly implement significant changes to clinical trials to keep them from coming to a complete halt. Now, they are grappling with if and how trial modifications should continue after the pandemic. They are also considering lessons learned from COVID-19 research that could be applied to cancer research.
COVID-19 Reshapes Cancer Clinical Research